Results
    Type
    Region
    Country of origin
    Qualifications

    Droxidopa | compare suppliers & send inquiries for free

    Here you will find a list of producers, manufacturers and traders of Droxidopa. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
    Spain Quimica Sintetica
    Type: Producer
    Produced in: Spain
    Unknown
    China JINLAN Pharm-Drugs Technology Co., Ltd.

    MOQ: 1 g
    Type: Producer
    Produced in: China
    China
    India Lupin
    Type: Producer
    Produced in: India
    India
    India Dasami Labs Private Limited

    MOQ: 15 kg
    Type: Producer
    Produced in: India
    India
    United States Apicore
    Type: Producer
    Produced in: United States
    India
    Ireland Clarochem
    Type: Producer
    Produced in: Ireland
    Ireland
    China Chongqing Shenghuaxi
    Type: Producer
    Produced in: China
    China
    India MSN Life Sciences
    Type: Producer
    Produced in: India
    India

    Looking for Droxidopa 23651-95-8?

    API | Excipient name:
    Droxidopa 
    Synonyms:
    L-Dihydroxyphenylserine, DOPS, L-DOPS, L-threo-dihydroxyphenylserine  
    Cas Number:
    23651-95-8 
    DrugBank number:
    DB06262 
    Unique Ingredient Identifier:
    J7A92W69L7

    About Droxidopa

    Here you will find more information about Droxidopa. Droxidopa is a precursor of noradrenaline that is used in the treatment of Parkinsonism. It is approved for use in Japan and is currently in trials in the USA The racaemic form (dl-threo-3-dihydroxyphenylserine) has also been used, and has been investigated in the treatment of orthostatic hypotension. There is a deficit of noradrenaline as well as of dopamine in Parkinson's disease and it has been proposed that this underlies the sudden transient freezing seen usually in advanced disease.

    Though L-DOPS has been used in Japan and Southeast Asia already for some time, it is also currently in clinical trials at the phase III point in the United States (USA), Canada, Australia, and throughout Europe. Provided L-DOPS successfully completes clinical trials, it could be approved for the treatment of neurogenic orthostatic hypotension (NOH) as early as 2011. Additionally, phase II clinical trials for intradialytic hypotension are also underway. Chelsea Therapeutics obtained orphan drug status (ODS) for L-DOPS in the USA for NOH, and that of which associated with Parkinson's disease , pure autonomic failure, and multiple system atrophy, and is the pharmaceutical company developing it in that country.

    Check who is selling Droxidopa in the overview above.

    Droxidopa manufacturers | traders | suppliers
    We have 8 companies offering Droxidopa from 4 different countries.

    Get in contact with the supplier of your choice:

    • JINLAN Pharm-Drugs Technology Co., Ltd. from China
    • Lupin from India
    • Dasami Labs Private Limited from India
    • Quimica Sintetica from Spain
    • MSN Life Sciences from India
    • Apicore from United States
    • Clarochem from Ireland
    • Chongqing Shenghuaxi from China

    Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

    You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.